Share blood and transplant samples for future research
Part of Blood & lymphatic, Cancer clinical trials.
This study builds a library of transplant and related medical samples to help scientists learn how to improve cell therapies and care for marrow injury. You may be included because you are a donor, receive a transplant or cell therapy, or are treated for marrow toxic injury at participating centers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a donor or recipient involved in a stem cell or other cellular therapy transplant
- If you’re a donor, you either already donated or are scheduled to donate to an allogeneic patient
- If you have a cord blood unit, the treatment center can submit testable specimens from participating units
- If you’re a recipient, you’re a U.S. patient receiving an allogeneic or autologous transplant or cellular therapy
- If you’re a marrow injury patient, you were treated at a participating center in the Radiation Injury Treatment Network
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health and treatment information in a large research database. It may help researchers better understand outcomes after blood stem cell transplants or bone marrow injury from treatment like radiation.
This trial is a registry that follows children and young adults up to age 26 who are having a bone marrow transplant, to better understand complications related to blood vessel and organ injury. It may help future patients by improving how doctors predict and prevent these problems.
This trial collects tissue, blood, and other body fluid samples from people with blood-related cancers. The goal is to help researchers study these diseases by building a source of samples for future testing.
This study aims to collect, store, and share data from patients who are receiving standard intensive treatment and a stem cell transplant from either their own cells or a donor. It may help improve how future patients are treated by building a reliable record of outcomes and care patterns.
This trial is a tissue and blood bank that collects samples for future research. You may be asked to give blood and/or tissue again later, but it is meant to be done without interfering with your care.
This study collects tissue samples from patients with cancer or blood disorders, and from their matching family members who might donate stem cells for transplant. The samples help researchers understand these diseases and develop better treatments.
Hear when a new Autologous Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.